Multimodal Identification of Depressive Symptoms in the Elderly
ConditionDepression
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-100
SponsorWuhan Mental Health Centre
About this trial
Screening with depression scales alone is subjective, and relying on single-modal data often leads to incomplete identification of symptoms that are easily missed or misdiagnosed. In this study, we first aim to use artificial intelligence to construct a depression symptom recognition model, concatenate multimodal features such as facial expression, audio, text, and postural behavior, and deeply fuse them to construct a multimodal model.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Elderly individuals aged 60 years or older.
Residents of the community (with residence time of more than 6 months).
Possessing certain reading, writing and comprehension skills, being able to communicate with researchers without obstacles, and being able to independently complete the measurement of various indicators or, although unable to independently fill out the questionnaire, being able to independently make evaluations of the questionnaire items.
Those who have given informed consent.
Disqualifiers
Those who meet the diagnostic criteria for cognitive impairment (dementia) as stipulated in DSM-5, and/or who suffer from severe physical diseases (such as advanced cancer, cardiovascular and cerebrovascular diseases, etc.).
Those who are undergoing antidepressant treatment.
Elderly individuals who have had suicidal thoughts in any psychological assessment, should be referred to the psychological hotline platform in Wuhan.
Trial population
Elderly individuals aged 60 years or older
Trial design
Design model
Ecologic or community
Time perspective
Cross-sectional
Treatments tested in this trial
data collection
Other interventionCollect the facial expressions, audio, text and postural behavior data of the respondents using electronic devices.
Treatment groups
2,000 Participants
are divided into 2 treatment groupsGroup A: non-depression1 intervention
Group B: depression1 intervention
Trial outcomes
Primary outcomes
1
Use the PHQ-9 (Patient Health Questionnaire - 9 ) to assess whether the respondents have depressive symptoms. The scale score is one point for each item.
If the PHQ-9 score is 5 or higher, it is determined as a positive sign of depressive symptoms.
Time frame
2025.09.01-2026.09.01Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: